ClinicalTrials.gg
Enrolling by invitationNCT06745375FLOSSUpdated Jan 21, 2026

Assessment of the Relationship of Soft Contact Lens Fit and Power (Fit & Lens pOwer Soft lenSes)

An interventional study of contact lens wear in Healthy Participants Study, Contact Lens Wear and Contact Lens Fit, sponsored by Aston University. Enrolling by invitation at 1 site in United Kingdom. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-21.

Sponsored by Aston University · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate whether altering the optical power (in dioptres) of a contact lens affects both vision and lens fit. As the majority of modern contact lens wearers prefer daily disposable soft lenses, the trial lenses used in this study-provided by CooperVision-reflect this trend, representing nearly 80% of the current UK market.

This study aims to generate data supporting the use of contact lenses with powers that do not precisely match a participant's visual prescription (within ±2.00 dioptres) as a viable temporary alternative when the exact required power is unavailable.

At present, there is no published literature in the context of modern contact lens design that compares the fitting characteristics of 'fit-for-purpose' lenses with those of lenses from the same design family that would not typically be selected due to power mismatch.

Read the detailed description

This study aims to evaluate the vision and fit of commercially available prescription contact lenses of different strengths to determine whether this affects the final lens selection and, if so, how. In addition, the study will compare subjective comfort and key fitting criteria such as centration, movement, tightness, coverage, and overall impression.

These data could help eye care practitioners use lenses they already have in stock instead of ordering new ones and requiring patients to return. Understanding whether these lenses fit similarly could make the process more convenient for both patients and practitioners. Patients would receive their lenses more quickly, and eye care providers could manage their existing stock more effectively.

The two visits will take place at the Aston University Eye Clinic. Data collection and assessments will include:

Participant's age, ethnicity, sex, and ocular history to determine eligibility [recorded electronically on a secure computer].

A standardised OSDI questionnaire (paper copy only), which quantifies dry eye symptoms, severity, and frequency (e.g. in the past week, how often participants' eyes felt gritty, watery, itchy, or burning, and how many times they experienced these symptoms), will be administered at the first visit after written consent. The completed questionnaire will be scanned and uploaded to BOX.

Both Visit One and Visit Two will include:

Application of contact lenses to the participant's eyes. Lens powers will be randomised between visits for each participant.

Comfort assessment using:

A visual analogue scale (paper-based) from "most comfortable" to "least comfortable," where participants mark their comfort level.

A numerical rating (1-10) of comfort, recorded electronically. Vision assessment after lens application, both objectively (autorefractor) and subjectively, as in routine clinical practice.

A video-recorded ocular assessment of the contact lens fit, including horizontal lens movement, blink-induced movement, and lens centration.

After data collection is complete and the lenses are removed at Visit Two, participants will be asked which lenses they preferred [recorded electronically].

The data collection follows standardised contact lens assessment protocols used in both primary and secondary care optometry.

A participant's current eye care practitioner will not be informed of their participation or the corresponding assessments/data unless clinically significant findings are discovered and the participant consents to sharing this information. Participants will be informed of the lens brand and manufacturer used in the study so that, if they find the lenses more comfortable than their current ones (if applicable) or are considering contact lenses, they may discuss this with their eye care practitioner.

02

Conditions studied

  • Healthy Participants Study
  • Contact Lens Wear
  • Contact Lens Fit

Keywords

  • contact lens
  • contact lens wear
  • contact lens fit
03

In context

Lead sponsor

Aston University is the lead sponsor of 27 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between 18-60 years of age
  • Vision correctable to at least 6/12 (20/40) or better in each eye
  • with mental capacity to provide written consent in English (as per the Mental Capacity Act, 2005).
  • happy to wear contact lenses

Exclusion criteria

Exclusion Criteria:

  • Any active infection or inflammation, history of major systemic or ophthalmic conditions
  • use of systemic or topical medications known to affect the eye in the previous 3 months
  • history of ocular surgery, currently enrolled on another study/clinical trial that may impact outcome
  • any other for typical contact lens wear
  • As per the Mental Capacity Act, 2005, participants will be automatically excluded if not deemed to have Capacity for consent or under the age of 18.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
38 participants (estimated)

Study arms

  • Experimental
    Healthy participants

    All healthy participants wear two different contact lenses, one with the correct power and one with +/- 2.00 Ds to actual refraction. All lenses are commercially available. No 2nd arm.

    Device: contact lens wear

Interventions

  • Devicecontact lens wear

    participants wear two different powered contact lenses (one with actual power, and one +/- 2.00Ds) contact lenses. No 2nd arm

06

What researchers measure

Primary outcomes

  1. Soft contact lens movement: Subjective and objective assessment of soft contact lens movement.

    Lens movements will be graded between 0.25 - 0.50 mm = Optimum, \<0.25 = Less movement; \>0.50mm is more movement.

    Time frame: within 30 mins of lens wear

  2. Soft contact lens horizontal lag:Subjective and objective assessment of soft contact lens lag.

    Lens lag will be graded as: \<50% lag = less leg, 50% to 100% is optimum lag, \>100% = high lag.

    Time frame: within 30 mins of lens wear

  3. Soft contact lens tightness: graded subjectively as optimum, loose and tight

    Soft contac tlens tightness

    Time frame: within 30 mins of lens wear

Secondary outcomes

  1. Assessment of ocular comfort with soft contact lenses

    Ocular comfort is graded by particpants 1-10 (1 being very uncomfortable and 10 being highly comfortable)

    Time frame: within 30 mins of lens wear

07

Study locations

1 site
  • School of Optometry, Aston Eye Clinic
    Birmingham, UK B4 7ET, United Kingdom
08

References and documents

Individual participant data

Plan to share: Undecided — This has not been planned, yet but there is no reason cant be done by the end of study.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2026; primary completion for Aug 2026, 7 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2024
First posted
Dec 20, 2024
StartEst.
Jan 30, 2026
Primary completionEst.
Aug 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Jan 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06745375
Lead sponsor
Aston University
Collaborators
CooperVision, Inc.
Responsible party
Sponsor
First posted
Dec 20, 2024
Start date
Jan 30, 2026 (estimated)
Primary completion
Aug 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jan 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion